Three Key Critical Considerations Before Embarking on Decentralized Trials

March 18, 2020

Sponsored Content

- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation

Related Content:

White Papers